Subscribe To This Blog

Friday, March 28, 2014

Nanomedicine is
essentially based on the medical application of nanotechnology in diagnosing,
treating and/or prevention of diseases and infections. Nanotechnology-based
drugs and treatments are applied for treating cardiovascular, neurological, and
oncology diseases.

Nanomedicine is based
on the utilization of knowledge pertaining to various nanoparticles, their
medical usages, and their actions within the human body.

There still exists
considerable scope for research in this domain, and scientists are currently
engaged in further studying the treatment-worthiness of a number of
nanoparticles such as fullerenes, dendrimers, drug conjugates, and nano
crystals.

It is important to note
that this area of medicine is still in its nascent stage mainly because it is a
niche research area and it receives comparatively less research funding.

Future
prospects of the nanomedicine market

A research report by
Transparency Market Research, a U.S.-based market research company, projects
that the nanomedicine market will be largely driven by partnerships between
global research firms and leading industry institutes. These collaborations
will play a crucial part in attracting more investments. The report states that
the global market for nanomedicine is projected to witness a compounded annual
growth rate (CAGR) of 12.3% between 2013 and 2019.

According to the market
research report by Transparency Market Research, oncology was the largest
application segment within the nanomedicine market with a total share of 38%.
This is attributed to the large scale focus on developing drugs and treatments
for cancer, and the fact that approved nanomedicine drugs also exist in the
market.

However, cardiovascular
applications of nanomedicine are regarded as being the fastest-growing segment
within the nanomedicine market. A large number of people being affected by
cardiovascular problems worldwide, and the availability of various devices
catering to the needs of this patient segment are growth influencers in this
market.

In addition, there has
been a perceptible increase in support from various governments in bolstering
research as well as product approvals within the nanomedicine segment; with
this support likely to continue, the market for nanomedicine will continue to
grow.

The
need for research, investment and collaboration in the nanomedicine market

In the coming years, it
is expected that further collaborations between academic institutes as well as
research firms will provided a much-needed boost to the role of nanomedicine in
chronic disease treatment.

Research and
breakthroughs could lead to the emergence of new treatments and technologies,
with more bioavailability.

Other factors such as a
growing demand and acceptance of targeted drug delivery (especially where
neurological disorders are concerned) has created a larger market for
nanomedicine.

On the other hand, the
prevalence of cardiovascular diseases is on the rise, and this trend asks for
the introduction of drugs that possess higher efficiency and better therapeutic
properties. This is yet another need that will propel demand for nanomedicine
products.

Nanomedicine has
already met with some success in oncology, and researchers and market players
alike are buoyed by this success. Having realized the efficacy of nanomedicine
in oncology, it is likely that the interest shown by market players to
commercialize products in this segment will only rise.

It is projected that
cardiovascular treatments are likely to emerge as the fastest growing market
within the nanomedicine market between 2013 and 2019.

Increased collaboration
between academic and research institutes will prove favorable for the
nanomedicine market. A noteworthy example of this would be the collaboration
between Elan Corporation Plc and Abbott Laboratories for the development of the
Tricor drug. This collaboration was key to helping both players lower cost
associated with research and development.

Looking forward, market
analysts expect that breakthroughs in nanomedicine will be crucial to the
development of treatments and products for diseases such as diabetes, cancer,
neurological disorders, and cardiovascular diseases.

Thursday, March 27, 2014

Transparency Market Research has launched a new market report titled "Flexible
Packaging (Plastic, Paper, Aluminum Foil and Others) Market for Food &
Beverages, Retail Non-Food, Pharmaceutical and Other Applications-Global
Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019,"
the global demand for flexible packaging was valued at USD 73.56 billion in
2012 and is expected to reach USD 99.10 billion in 2019, growing at a CAGR of
4.4% from 2013 to 2019. In terms of volume, the demand was 18,666.0 kilo tons
in 2012 and is expected to be 24,728.7 kilo tons in 2019, growing at a CAGR of
4.1% from 2013 to 2019.

Increasing demand for flexible packaging in the healthcare industry is
expected to be one of the key factors driving growth of the flexible packaging
market. In addition, expansion of the food & beverages market, which is the
largest application of flexible packaging, is expected to fuel the growth of
the market. Furthermore, rising consumer preference towards light weight,
durable and highly aesthetic flexible packaging is expected to significantly
fuel the growth of the market over the next few years. However, volatility in
the prices of crude oil which consequently affects the prices of its downstream
chemicals is expected to hamper the packaging market adversely. Focused
research and development activities on flexible packaging technologies have
opened opportunities for the usage of nanotechnology in the formation of films
and printing.

Plastics have been extensively used in flexible packaging due to their
high barrier properties, cost effectiveness and durability and accounted for
over 70% of the market share in 2012. However, growing consumer demand for
biodegradable packaging material due to rising awareness regarding ecology
conservation is expected is boost the demand for cellulose over the next six
years. In addition, cellulose has been popular than other packaging materials
due to its high durability, protection from external environmental factors such
as sunlight and high aesthetic value. These factors are expected to contribute
significantly to the growing demand for cellulose.

Demand for flexible packaging was highest from the food & beverages
sector. Several regulations are being introduced and implemented across the
world regarding packaging of pharmaceuticals due to various factors such as
maintenance of hygiene, reduction of fraudulent drugs in the retail market and
to retain the medicinal properties of the drug. Thus, flexible packaging is
expected to witness the fastest growth in pharmaceutical within the forecast
period and is expected to be valued at USD 11.09 billion in 2019.

Asia Pacific accounted for the highest demand in 2012, and is expected to
be fastest growing region, rising at a CAGR of 4.4% from 2013 to 2019. This
trend is expected to continue over the forecast period on account of rapid
economic development in this region resulting in the growth of various
industries such as food & beverages, personal care products and
pharmaceuticals among others. Regions present in rest of the world are expected
to witness a significant increase in consumption of packaging owing to economic
development in countries such as Brazil.

The
report gives a comprehensive view of the flexible packaging market in
terms of volume and revenue. In addition, the report includes current
demand
analysis and forecast for each product and application in North America,
Europe, Asia Pacific and Rest of the World. The report comprises of the
following
segments:

Tuesday, March 25, 2014

Transparency Market Research has launched a new market report titled “Feed Acid Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019“. According to the report, the demand for feed acid is expected to grow at a CAGR of 6.3% in terms of revenue from 2013 to 2019 and the market was valued at USD 1,162.3 million in 2012, is expected to reach USD 1,779.3 million by 2019.

The global market for feed acid witnessed growth in recent years due to growing demand for meat and meat products across the globe. In addition, disease outbreaks increased the need for feed acids which is another factor in driving market growth. Availability of different alternatives in the market for feed acid is the major growth barrier to the market. However, increasing ban on antibiotics in different countries provides a huge opportunity for the market players.

In 2012, Europe and North America dominated feed acid market that accounted for more than 60% of the marketshare. Europewas the biggest market for feed acids followed by North America. This dominance was driven by the ban on antibiotics used as a growth promoter in animal feed and the increasing demand for improving feed utilization. But in future, both these economies are expected to lose their market share. Looking ahead, Asia Pacific and RoW regions are expected to increase their market share and Asia Pacific is also expected to be the fastest growing market. The Asia Pacific market is expected to grow at a CAGR of 6.6% from 2013 to 2019. This is due to an increase in the population and rising middle class income which accounts for a higher demand for meat.

The global market for feed acid consists of large numbers of small and medium scale manufacturers. But only some of the players accounted for the significant market share in 2012. Most of the companies depend upon a third party distribution to reach their customers, whereas some of themarket playersdirectly reach their target consumers through the industry participants by their own distribution network, or through integrated producers. Some of the key players of the market are BASF SE, ADM Alliance Nutrition, Inc, Provimi SA, Yara International ASA, and Trouw Nutrition International B.V. among many others.

Increasing health awareness and changing consumer groups are the major growth drivers for the global Sports Nutrition market. Traditionally, bodybuilders and athletes were the only consumers for sports nutrition products. In recent years, new user groups (recreational and lifestyle users) have increased their market share. The market is also witnessing a shift from major markets (North America) towards developing markets in Europe and Asia Pacific. Due to high population, countries such as India and China offer huge opportunities in the future. Furthermore, upcoming high profile sporting events allow sports nutrition companies to establish themselves in these markets.

The report covers in-depth analysis of Sports Nutrition market, by product segment (Sports Food, Sports Drinks and Sports Supplements) for the period from 2010 to 2019. In addition, the current market dynamics including the drivers, restraints, trends and recent developments have been captured throughout the report. The market for the major countries in each of the four regions, North America, Europe, Asia Pacific and Rest of the World includes historical and forecasted market sizes (2010-2019), in terms of value. North America region covers the scenario in the U.S. and Canada. Europe region covers the scenario of the U.K., Germany, Italy and France. Asia-Pacific region highlights the scenario in Australia, Japan, India and China.

The Competitive Landscape section of the report includes the positioning of different companies on the basis of their geographical presence and product offerings. Some of the major players in this market are Maxinutrition, Glanbia, PepsiCo, Coca-Cola and Clif Bar & Company. The company profiles include attributes such as company overview, financial performance, and strategic developments.